Welcome to HitGen


One-stop Technology Platform to Accelerate Drug Discovery and Development

  1. Capabilities
  2. DEL for

DEL for

DNA encoded library (DEL) selection has been applied on various target classes and different modalities, yielding ligands progressed into different stages of drug development. In this session, we review the major advantages and potential challenges of DEL selection on diverse targets including PPI, kinases, GPCRs, RNAs and etc., as well as different modalities like covalent ligands and Protein degraders.

If you are interested in our DEL FOR series, please download the documentation. We also welcome you to browse the content of your interest within our website

Thanks for reading!

For more details on how we can advance your innovative drug discovery projects
By submitting your information, you acknowledge having received, read and understood our Privacy Notice as made available above.

We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for More information